ZA922139B - Topical preparation containing a suspension of solid lipid particles - Google Patents

Topical preparation containing a suspension of solid lipid particles

Info

Publication number
ZA922139B
ZA922139B ZA922139A ZA922139A ZA922139B ZA 922139 B ZA922139 B ZA 922139B ZA 922139 A ZA922139 A ZA 922139A ZA 922139 A ZA922139 A ZA 922139A ZA 922139 B ZA922139 B ZA 922139B
Authority
ZA
South Africa
Prior art keywords
suspension
preparation containing
lipid particles
solid lipid
topical preparation
Prior art date
Application number
ZA922139A
Other languages
English (en)
Inventor
Tom De Vringer
De Vringer Tom
Original Assignee
Brocades Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8207568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA922139(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brocades Pharma Bv filed Critical Brocades Pharma Bv
Publication of ZA922139B publication Critical patent/ZA922139B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
ZA922139A 1991-03-25 1992-03-24 Topical preparation containing a suspension of solid lipid particles ZA922139B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200664 1991-03-25

Publications (1)

Publication Number Publication Date
ZA922139B true ZA922139B (en) 1992-11-25

Family

ID=8207568

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922139A ZA922139B (en) 1991-03-25 1992-03-24 Topical preparation containing a suspension of solid lipid particles

Country Status (19)

Country Link
US (2) US5667800A (de)
EP (2) EP0506197B2 (de)
JP (1) JP2947668B2 (de)
KR (1) KR100212926B1 (de)
AT (2) ATE231720T1 (de)
AU (1) AU658608B2 (de)
CA (1) CA2063862C (de)
DE (2) DE69232914T2 (de)
DK (2) DK0786251T3 (de)
ES (2) ES2119793T5 (de)
FI (1) FI108277B (de)
HU (1) HU213669B (de)
IE (1) IE920929A1 (de)
IL (1) IL101352A (de)
NO (1) NO303667B1 (de)
NZ (1) NZ242101A (de)
PT (1) PT786251E (de)
TW (1) TW206156B (de)
ZA (1) ZA922139B (de)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250236A (en) † 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
FR2687569B1 (fr) * 1992-02-21 1995-06-09 Oreal Composition cosmetique pour le maquillage des yeux, comprenant une microdispersion de cire.
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
EP0877050B1 (de) * 1992-09-15 2008-05-21 Dow Global Technologies Inc. Schlagzähmodifizierung von Thermoplasktiken
CA2091152C (en) * 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
US6113921A (en) * 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
DE4336407A1 (de) * 1993-10-21 1995-04-27 Rotring Int Gmbh Wasserfeste Kosmetik
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US6472042B1 (en) 1994-02-10 2002-10-29 Dow Global Technologies Inc. Highly filled thermoplastic compositions
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
FR2721210B1 (fr) * 1994-06-17 1996-08-02 Oreal Composition de nettoyage contenant des grains lipidiques.
US5672358A (en) * 1994-06-21 1997-09-30 Ascent Pharmaceuticals, Inc. Controlled release aqueous emulsion
US5629021A (en) * 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
FR2734480B1 (fr) * 1995-05-22 1997-08-08 Gueyne Edith Composition cosmetique pour la peau comprenant une nanodispersion de corps gras dans l'eau
US7338698B1 (en) 1997-02-28 2008-03-04 Columbia Insurance Company Homogeneously branched ethylene polymer carpet, carpet backing and method for making same
AU6344098A (en) 1997-02-28 1998-09-18 Shaw Industries, Inc. Carpet, carpet backings and methods
KR20000075675A (ko) 1997-02-28 2000-12-26 그래햄 이. 테일러 충전된 폴리에틸렌 조성물
US20030211280A1 (en) 1997-02-28 2003-11-13 Shaw Industries, Inc. Carpet, carpet backings and methods
DK1032378T3 (da) * 1997-11-25 2002-04-15 Yamanouchi Europ Bv Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme
DE19832888A1 (de) * 1998-07-22 2000-01-27 Beiersdorf Ag Pflegende kosmetische und dermatologische Zubereitungen mit einem Gehalt an Fettsäuren
DE19832890A1 (de) * 1998-07-22 2000-01-27 Beiersdorf Ag Pflegende kosmetische und dermatologische Zubereitungen mit einem Gehalt an Fettalkoholen
US6345775B1 (en) 1998-07-30 2002-02-12 Wilsoart International, Inc. Very high solid content aerosol delivery system
DE19834813A1 (de) * 1998-08-01 2000-02-03 Beiersdorf Ag Verwendung von Glycerin- und/oder Glykolestern langkettiger, aliphatischer, verzweigter und/oder unverzweigter Fettsäuren in kosmetischen und dermatologischen Zubereitungen zur Stärkung der Barrierefunktion der Haut
DE19837191A1 (de) * 1998-08-17 2000-02-24 Henkel Kgaa Kosmetische und dermatologische Hautbehandlungsmittel
JP2002527367A (ja) * 1998-10-14 2002-08-27 コグニス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ナノスケールのステロールおよびステロールエステルの使用
DE19856728B4 (de) * 1998-12-09 2004-04-22 Henkel Kgaa Verfahren zur Herstellung von Nanopartikeldispersionen
DE19911058B4 (de) * 1999-03-12 2004-09-30 Biotec Asa Verwendung von nanoskaligen wasserlöslichen β-(1,3)-Glucanen
DE19920555B4 (de) * 1999-05-05 2004-08-26 Cognis Deutschland Gmbh & Co. Kg Verwendung von nanoskaligen Metallseifen
US8663692B1 (en) 1999-05-07 2014-03-04 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
US6896205B2 (en) 1999-05-21 2005-05-24 Premark Rwp Holdings, Inc. Very high solid content aerosol delivery system
WO2001003652A2 (de) * 1999-07-13 2001-01-18 Pharmasol Gmbh Mittel mit uv-strahlung absorbierender und/oder reflektierender wirkung zum schutz vor gesundheitsschädlicher uv-strahlung und stärkung der natürlichen hautbarriere
DE19938404A1 (de) * 1999-08-13 2001-02-22 Clariant Gmbh Kosmetische Zubereitungen
DE19958521A1 (de) * 1999-12-04 2001-06-07 Cognis Deutschland Gmbh Verwendung von nanoskaligen Wachsen
US7153525B1 (en) * 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
DE10027948A1 (de) * 2000-06-08 2001-12-20 Henkel Kgaa Verfahren zur Herstellung von Nanopartikel-Suspensionen
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
DE10059668A1 (de) * 2000-12-01 2002-06-20 Henkel Kgaa Verwendung von nanopartikulären Wachsen in der Hautkosmetik
AU2002219198B2 (en) * 2000-12-27 2006-06-29 Ares Trading S.A. Lipid microparticles by cryogenic micronization
US6491902B2 (en) 2001-01-29 2002-12-10 Salvona Llc Controlled delivery system for hair care products
US6979440B2 (en) 2001-01-29 2005-12-27 Salvona, Llc Compositions and method for targeted controlled delivery of active ingredients and sensory markers onto hair, skin, and fabric
US20030129253A1 (en) * 2002-01-03 2003-07-10 Milley Christopher J. Stable aqueous suspension
EP1329212B1 (de) * 2002-01-21 2009-11-18 Unilever N.V. Haarbehandlungsmittel
DE60234420D1 (de) 2002-01-21 2009-12-31 Unilever Nv Haarbehandlungsmittel
ATE387908T1 (de) 2002-01-21 2008-03-15 Unilever Nv Shampoo enthaltend ein silikonwachs
CA2474633A1 (en) * 2002-02-08 2003-08-14 The Procter & Gamble Company Rinse-off skin conditioning compositions comprising solid particulates and a lipophilic carrier
US20030211069A1 (en) 2002-05-09 2003-11-13 The Procter & Gamble Company Rinsable skin conditioning compositions
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20040120974A1 (en) * 2002-12-23 2004-06-24 Ajinomoto Usa, Inc. Powder concentrates, methods of preparing the same, methods of using the same, and emulsified personal care products prepared from the same
DE10312763A1 (de) * 2003-03-21 2004-09-30 IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG Verfahren zur Herstellung einer SLN-Dispersion
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
AU2003239845A1 (en) * 2003-05-07 2004-11-26 Ifac Gmbh And Co.Kg Compositions for the targetted release of fragrances and aromas
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
WO2005041933A1 (en) * 2003-10-31 2005-05-12 Teva Pharmaceutical Industries, Ltd. Nanoparticles for drug delivery
GB0427568D0 (en) * 2004-12-16 2005-01-19 Resolution Chemicals Ltd Particle-size reduction apparatus, and the use thereof
US8147853B2 (en) 2005-02-15 2012-04-03 The Procter & Gamble Company Personal care compositions containing hydrophobically modified non-platelet particles
JP4533185B2 (ja) * 2005-02-24 2010-09-01 花王株式会社 固体脂質粒子製剤
CA2600054A1 (en) * 2005-03-09 2006-09-21 Combe Incorporated Stable mixed emulsions
FR2885538B1 (fr) * 2005-05-16 2007-08-10 Univ Claude Bernard Lyon Nouveau procede de preparation de particules lipidiques solides, mettant en oeuvre un reacteur membranaire
US7300912B2 (en) * 2005-08-10 2007-11-27 Fiore Robert A Foaming cleansing preparation and system comprising coated acid and base particles
US20070065390A1 (en) * 2005-09-19 2007-03-22 Eric Spengler Stable emulsion systems with high salt tolerance
AU2006299421B2 (en) * 2005-10-03 2013-01-31 Mark A. Pinsky Compositions and methods for improved skin care
US8876754B2 (en) 2006-08-31 2014-11-04 Bayer Medical Care Inc. Catheter with filtering and sensing elements
KR100941854B1 (ko) * 2006-09-01 2010-02-11 (주)아모레퍼시픽 오메가-3 지방산을 함유하는 피부 외용제 조성물
ITMI20061918A1 (it) * 2006-10-06 2008-04-07 Nanovector S R L Formulazioni adatte ad essere somministrate per via transdermica contenenti principi attivi incorporati in sln
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20100098752A1 (en) * 2007-01-18 2010-04-22 Pinsky Mark A Materials and Methods for Delivering Antioxidants into the Skin
US8529951B1 (en) * 2007-02-21 2013-09-10 Anand Ramamurthi Elastogenic cues and methods for using same
US8309129B2 (en) 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
US9545384B2 (en) 2007-06-04 2017-01-17 Bend Research, Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
EP2162120B1 (de) 2007-06-04 2016-05-04 Bend Research, Inc Nanopartikel mit nicht ionisierbarem zellulosepolymer und amphipilem nicht ionisierbarem blockcopolymer
CN101322712B (zh) * 2007-06-14 2010-10-13 沈阳市万嘉生物技术研究所 一种前列地尔纳米粒制剂及其制备方法
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
WO2009073216A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
US20090169615A1 (en) * 2007-12-26 2009-07-02 Pinsky Mark A Collagen Formulations for Improved Skin Care
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
CN102099015B (zh) * 2008-07-18 2015-05-06 拜奥莫达概念公司 释放活性成分的制品
CA2757310A1 (en) 2009-04-08 2010-10-14 Cadila Healthcare Limited Stable pharmaceutical compositions of diclofenac
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US20110033545A1 (en) * 2009-08-06 2011-02-10 Absize, Inc. Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
CA2776474C (en) 2009-10-02 2021-01-12 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10758630B2 (en) 2010-08-13 2020-09-01 The Johns Hopkins University Topical compositions and methods of detection and treatment
WO2012053012A2 (en) 2010-10-21 2012-04-26 Cadila Healthcare Limited Topical pharmaceutical compositions comprising tfflocolchicoside
WO2012053009A2 (en) 2010-10-21 2012-04-26 Cadila Healthcare Limited Pharmaceutical compositions comprising skin whitening agents
MX2013004296A (es) 2010-10-21 2013-09-26 Cadila Healthcare Ltd Composiciones farmaceuticas topicas que contienen gotas de tamaño nanometrico para el tratamiento de soriasis.
US9789123B2 (en) 2010-10-21 2017-10-17 Cadila Healthcare Limited Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
US20130295145A1 (en) 2010-10-21 2013-11-07 Cadila Healthcare Limited Topical pharmaceutical compositions comprising etodolac
WO2012059936A1 (en) 2010-11-03 2012-05-10 Padma Venkitachalam Devarajan Pharmaceutical compositions for colloidal drug delivery
WO2012127496A1 (en) 2011-03-01 2012-09-27 Cadila Healthcare Limited Stable pharmaceutical compositions of lornoxicam or salts thereof
JP2014508796A (ja) * 2011-03-24 2014-04-10 レオ ファーマ アクティーゼルスカブ 脂質ナノ粒子とコルチコステロイドまたはビタミンｄ誘導体とを含む組成物
US9713590B2 (en) 2011-07-28 2017-07-25 Cadila Healthcare Limited Method for treatment of pain and inflammation
US9861645B2 (en) 2012-12-28 2018-01-09 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations
EP2823811A1 (de) * 2013-07-09 2015-01-14 OTC GmbH Gerichtetes aktives Freisetzungssystem mit festen Lipidnanopartikeln
US20160361264A1 (en) * 2015-06-12 2016-12-15 Salvona Llc Delivery of pharmaceutical active ingredients through the skin and hair follicles into dermis and transdermal delivery
US10543156B2 (en) * 2015-06-18 2020-01-28 The Procter & Gamble Company Shaping keratin fibres using 2-oxazolidinone compounds
US10792293B2 (en) 2015-07-31 2020-10-06 Hamidreza Kelidari Topical nanodrug formulation
US20180117058A1 (en) * 2015-10-07 2018-05-03 Cormedix Inc. Skin-penetrating formulation of taurolidine
CA3000868A1 (en) * 2015-10-07 2017-04-13 Cormedix Inc. Skin-penetrating formulation of taurolidine
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
BR112019009554B1 (pt) * 2017-04-13 2023-01-31 The Procter & Gamble Company Método para preparação de uma composição de produto compreendendo uma partícula distinta e uma composição-base aquosa
US11931441B2 (en) 2018-10-10 2024-03-19 The Procter & Gamble Company Personal care product customized by discrete particles and method of apply thereof
DE102019206788A1 (de) * 2019-05-10 2020-11-12 Beiersdorf Ag Wässrige kosmetische Zubereitung mit dispergierten Wachspartikeln
CN110403908B (zh) * 2019-08-30 2022-02-15 华南理工大学 一种食品级脂质皮克林乳液及制备方法
US20220362155A1 (en) * 2021-05-03 2022-11-17 Mcal Therapeutics Inc. Micronized lipids
US20220362154A1 (en) * 2021-05-03 2022-11-17 Mcal Therapeutics Inc. Micronized lipids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014509A3 (de) * 1979-02-08 1981-02-11 THE PROCTER & GAMBLE COMPANY Zusammensetzungen zum Konditionieren der Haut
ATE15901T1 (de) * 1981-01-21 1985-10-15 Unilever Nv Lipide und proteine in teilchenform enthaltender stoff und verfahren zu seiner herstellung.
FR2520253A1 (fr) * 1982-01-28 1983-07-29 Oreal Nouveau systeme emulsionnant a base d'un condensat de proteines, d'un sterol polyoxyethylene et de phosphatide et son utilisation en cosmetique
DE3585967D1 (de) * 1984-03-08 1992-06-11 Phares Pharma Holland Liposombildende zusammensetzung.
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US5023108A (en) * 1986-01-13 1991-06-11 Research Corporation Aqueous dispersions of waxes and lipids for pharmaceutical coating
US5174930A (en) * 1986-12-31 1992-12-29 Centre National De La Recherche Scientifique (Cnrs) Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of oligolamellar liposomes of submicron dimensions
LU87457A1 (fr) † 1989-02-24 1990-09-19 Oreal Utilisation,comme composition cosmetique pour cheveux,d'une microdispersion de cire,et procede de traitement des cheveux avec une telle composition
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution

Also Published As

Publication number Publication date
FI108277B (fi) 2001-12-31
FI921251A (fi) 1992-09-26
PT786251E (pt) 2003-06-30
CA2063862A1 (en) 1992-09-26
KR920017642A (ko) 1992-10-21
KR100212926B1 (ko) 1999-08-02
AU1297892A (en) 1992-10-01
DE69225917T3 (de) 2001-10-04
EP0786251A2 (de) 1997-07-30
ES2191806T3 (es) 2003-09-16
DK0506197T4 (da) 2001-11-12
DE69225917T2 (de) 1998-12-10
DK0506197T3 (da) 1998-10-19
EP0786251B1 (de) 2003-01-29
IE920929A1 (en) 1992-10-07
ES2119793T3 (es) 1998-10-16
US5904932A (en) 1999-05-18
DE69232914D1 (de) 2003-03-06
CA2063862C (en) 2000-03-28
TW206156B (de) 1993-05-21
EP0786251A3 (de) 1997-08-06
NO921157D0 (no) 1992-03-24
AU658608B2 (en) 1995-04-27
FI921251A0 (fi) 1992-03-23
US5667800A (en) 1997-09-16
JP2947668B2 (ja) 1999-09-13
ATE231720T1 (de) 2003-02-15
HU213669B (en) 1997-09-29
NZ242101A (en) 1993-12-23
NO303667B1 (no) 1998-08-17
DE69232914T2 (de) 2003-08-07
IL101352A (en) 1996-05-14
HU9200977D0 (en) 1992-05-28
HUT60621A (en) 1992-10-28
ATE167395T1 (de) 1998-07-15
EP0506197B1 (de) 1998-06-17
EP0506197A1 (de) 1992-09-30
ES2119793T5 (es) 2001-12-01
DE69225917D1 (de) 1998-07-23
EP0506197B2 (de) 2001-07-04
NO921157L (no) 1992-09-28
IL101352A0 (en) 1992-11-15
JPH05262641A (ja) 1993-10-12
DK0786251T3 (da) 2003-05-19

Similar Documents

Publication Publication Date Title
ZA922139B (en) Topical preparation containing a suspension of solid lipid particles
EP0167825A3 (en) Lipid nano pellets as drug carriers for oral administration
CA2089003A1 (en) Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
DK88692D0 (da) Fremgangsmaade til fremstilling af mikrokapsler
CA2128706A1 (en) Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain
EP0305400A4 (de) Fettsäure und cyclosporin enthaltende zusammensetzung mit ermässigter nephrotoxizität.
HUT46851A (en) Process for producing improves pharmaceutical compositions containing flunarazine
GR3033990T3 (en) Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics
GR3035613T3 (en) Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
CA2146141A1 (en) Triglyceride fractionation
GR861402B (en) Emulsifier and method for its preparation
EP0422490A3 (en) Triglycerides containing saturated fatty acids having 20 to 24 carbon atoms useful in lowering blood cholesterol levels
CA2203566A1 (en) Percutaneously administration preparation
ES8401721A1 (es) Un procedimiento para la produccion de una composicion de fenortrazina inyectable.
EP0320609A3 (de) Anionisches Oberflächenleimungsmittel für Papier
CA2222161A1 (en) Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
JPS57136508A (en) Whitening cosmetic
Zaitseva et al. Study of the structure of yeast triacylglycerols.
Soppela Characteristics of fatty acid composition of adipose tissue and serum lipids in reindeer calves
CS906388A1 (en) Method of compacts preparation with application of higher fatty acids' uranyl salts as lubricant